Abstract
We report the isolation, functional characterization, and localization of a Na+/Cl−-dependent catecholamine transporter (meNET) present in the brain of the teleost fish medaka. This carrier is very similar to the human neuronal norepinephrine transporter (NET) and the human neuronal dopamine transporter (DAT), showing 70 and 64% amino acid identity, respectively. When expressed in COS-7 cells, this transporter mediates the high-affinity uptake of dopamine (KM = 290 nM) and norepinephrine (KM = 640 nM). Its pharmacological profile reveals more similarities with NET, including a high affinity for the tricyclic antidepressants desipramine (IC50 = 0.92 nM) and nortriptyline (IC50 = 16 nM). In situ hybridization on the medaka brain shows that meNET mRNA is present only in a subset of tyrosine hydroxylase-positive neurons found in the noradrenergic areas of the hindbrain, such as the locus ceruleus and area postrema. None of the dopaminergic areas anterior to the isthmus contains any labeled neurons. Neither reverse transcriptase-polymerase chain reaction with degenerate primers specific for γ-aminobutyric acid transporter/NET nor autoradiographic experiments with [125I]3b-(4-iodophenyl)-tropane-2b-carboxylic acid methyl ester revealed an additional catecholamine transporter in the medaka brain. Uptake experiments with medaka brain synaptosomes show an endogenous transport with a pharmacological profile identical to that of the recombinant meNET. Thus, meNET is probably the predominant—if not the only—catecholamine transporter in the medaka fish brain. In view of the highly conserved primary structures and pharmacological properties of meNET, it is tempting to speculate that a specific dopamine transport developed later in vertebrate evolution and probably accompanied the tremendous enlargement of the meso-telencephalic dopaminergic pathways in amniotes.
Footnotes
-
↵1 Present address: Sanofi-Synthelabo, Département SNC, 34184 Montpellier Cedex 04, France.
-
This research was supported by grants from Institut National de la Santé et de la Recherche Médicale (to B.G.) and from Centre National de la Recherche Scientifique and University Paris XI (to P.V.). C.R. was supported by Sanofi Recherche and Fondation pour la Recherche Medicale. M.K. was supported by Lilly and Fondation pour la Recherche Medicale. C.S. was supported by Rhône-Poulenc Rorer and Association France Parkinson.
- Abbreviations:
- DA
- dopamine
- NE
- norepinephrine
- DAT
- dopamine transporter
- NET
- norepinephrine transporter
- TMD
- transmembrane domain(s)
- fET
- Rana catesbiana peripheral epinephrine transporter
- ceDAT
- Caenorhabditis elegans dopamine transporter
- RTI-55
- 3b-(4-iodophenyl)-tropane-2b-carboxylic acid methyl ester
- meNET
- medaka norepinephrine transporter
- PCR
- polymerase chain reaction
- SSC
- standard saline citrate
- RT
- reverse transcriptase
- PBS
- phosphate-buffered saline
- SERT
- serotonin transporter
- hNET
- human norepinephrine transporter
- GAT
- γ-aminobutyric acid transporter
- GABA
- γ-aminobutyric acid
- rDAT
- rat dopamine transporter
- TH
- tyrosine hydroxylase
- PKC
- protein kinase C
- Received March 2, 2001.
- Accepted May 25, 2001.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|